BTCY
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q3 | -0.04 | $4M | -$740,291 |
| 2025 Q2 | -0.03 | $4M | $415,630 |
| 2025 Q1 | -0.03 | $4M | -$373,389 |
| 2025 Q4 | -0.09 | $4M | -$400,785 |
| 2024 Q3 | -0.05 | $4M | -$88,093 |
| 2024 Q2 | -0.07 | $3M | -$397,059 |
| 2024 Q1 | -0.49 | $3M | -$1M |
| 2024 Q4 | -0.46 | $3M | -$1M |